Internet Archive Scholar

POPULATION PHARMACOKINETICS OF AMIKACIN IN NEONATAL INTENSIVE CARE UNIT PATIENTS

Paulo Caceres Guido, Monica Travaglianti, Graciela Castro, Nieves Licciardone, Oscar Ferreyra, Guillermo Bramuglia, Facundo Garcia Bournissen, Paula Schaiquevich
2017 Australasian Medical Journal  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (616.4 kB)
https://web.archive.org/web/20200311103950/https://ri.conicet.gov.ar/bitstream/handle/11336/78246/CONICET_Digital_Nro.2f58f8b8-ef2e-4500-8c7c-e36f1786b241_A.pdf;jsessionid=A3F71A398E4CF75FF48455B9ADC63BC6?sequence=2

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Amikacin treatment requires close monitoring of blood concentrations to increase the probability that levels achieved are both effective and safe.
doi:10.21767/amj.2017.2833 fatcat:g6db2bqetbdhfonbqv7sn3hkr4
DOAJ OJS
Citation

Paulo Caceres Guido, Monica Travaglianti, Graciela Castro, Nieves Licciardone, Oscar Ferreyra, Guillermo Bramuglia, Facundo Garcia Bournissen, Paula Schaiquevich. "POPULATION PHARMACOKINETICS OF AMIKACIN IN NEONATAL INTENSIVE CARE UNIT PATIENTS." Australasian Medical Journal 10.02 (2017)